VVP
AZN icon

Venture Visionary Partners’s AstraZeneca AZN Stock Holding History

Venture Visionary Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
6,353
+246
+4% +$46.3K 0.03% 313
2026
Q1 		$1.2M Sell
6,107
-130
-2% -$25.1K 0.04% 292
2025
Q4 		$1.15M Sell
6,237
-5
-0.1% -$877 0.04% 297
2025
Q3 		$958K Sell
6,242
-15
-0.2% -$2.27K 0.03% 302
2025
Q2 		$874K Buy
6,257
+363
+6% +$50.9K 0.03% 300
2025
Q1 		$866K Sell
5,894
-10
-0.2% -$1.45K 0.04% 294
2024
Q4 		$774K Sell
5,904
-64
-1% -$8.96K 0.03% 296
2024
Q3 		$930K Sell
5,968
-58
-1% -$9.36K 0.04% 281
2024
Q2 		$940K Buy
6,026
+91
+2% +$13.7K 0.04% 281
2024
Q1 		$804K Buy
5,935
+202
+4% +$26.7K 0.04% 301
2023
Q4 		$772K Buy
5,733
+118
+2% +$15.3K 0.04% 288
2023
Q3 		$760K Hold
5,615
– – 0.05% 271
2023
Q2 		$804K Sell
5,615
-45
-0.8% -$6.62K 0.05% 273
2023
Q1 		$786K Buy
5,660
+28
+0.5% +$3.77K 0.05% 265
2022
Q4 		$764K Sell
5,632
-600
-10% -$75.2K 0.06% 252
2022
Q3 		$683K Sell
6,232
-57
-0.9% -$7.23K 0.06% 253
2022
Q2 		$831K Hold
6,289
– – 0.06% 226
2022
Q1 		$834K Buy
6,289
+168
+3% +$20.1K 0.06% 243
2021
Q4 		$713K Hold
6,121
– – 0.05% 273
2021
Q3 		$735K Hold
6,121
– – 0.05% 256
2021
Q2 		$733K Sell
6,121
-37
-0.6% -$4.06K 0.06% 247
2021
Q1 		$612K Buy
6,158
+1,264
+26% +$127K 0.05% 273
2020
Q4 		$489K Buy
+4,894
New +$518K 0.05% 240

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Venture Visionary Partners's AZN Position: Q2 2026 in Review

Venture Visionary Partners increased its AstraZeneca (AZN) stake by 4% in Q2 2026, buying an estimated $46.3K and bringing the position to 6,353 shares worth $1.2M. The position accounts for 0.03% of the portfolio, ranked #313.

Venture Visionary Partners first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Venture Visionary Partners held 6,353 shares of AstraZeneca worth $1.2M as of Q2 2026.
  • Venture Visionary Partners bought 246 AstraZeneca shares in Q2 2026, an estimated $46.3K.
  • AstraZeneca made up 0.03% of Venture Visionary Partners's portfolio in Q2 2026, its #313 holding.
  • Venture Visionary Partners first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.